Abstract
Multimodal treatment strategies, using chemotherapy combined with radiotherapy within clinical multicenter trials, have improved survival of children and adolescents with lymphoma. The role of surgery in the treatment of children with lymphomas is limited to diagnostic biopsies and to tumor- or treatment-related complications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Akbayram S, Dogan M, Akgün C, et al. Use of rituximab in three children with relapsed/refractory Burkitt lymphoma. Target Oncol. 2010;5(4):291–4.
Appel BE, Chen L, Buxton A, et al. Impact of low-dose involved-field radiation therapy on pediatric patients with lymphocyte-predominant Hodgkin lymphoma treated with chemotherapy: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2012;59(7):1284–9.
Bonadonna G, Zucali R, Monfardini S, et al. Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer. 1975;36:252–9.
Burkhardt B, Zimmermann M, Oschlies I, et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol. 2005;131:39–49.
Burkhardt B, Oschlies I, Klapper W, et al. Non-Hodgkin’s lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols. Leukemia. 2011;25:153–60.
Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin’s disease staging classification. Cancer Res. 1971;31:1860–1.
Castellino SM, Geiger AM, Mertens AC, et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood. 2011;117(6):1806–16.
Chu Y, Gardenswartz A, Termuhlen AM, et al. Advances in cellular and humoral immunotherapy - implications for the treatment of poor risk childhood, adolescent, and young adult B-cell non-Hodgkin lymphoma. Br J Haematol. 2019;185(6):1055–70.
Devita VT Jr, Serpick AA, Carbone PP. Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 1970; 73:881–895.
Dörffel W, Lüders H, Rühl E, et al. Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin’s disease in children and adolescents: analysis and outlook. Klin Pädiatr. 2003;215:139–45.
Dörffel W, Rühl U, Lüders H, et al. Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. J Clin Oncol. 2013;31(12):1562–8.
Galper SL, Yu JB, Mauch PM, et al. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood. 2011;117(2):412–8.
Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361–92.
Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.
Jerusalem G, Beguin Y, Fassotte MF, et al. Whole-body positron emission tomography using 18F- fluorodeoxyglucose for posttreatment evaluation in Hodgkin’s disease and non- Hodgkin’s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood. 1999;94:429–33.
Kluge R, Kurch L, Montravers F, et al. FDG PET/CT in children and adolescents with lymphoma. Pediatr Radiol. 2013;43:406–17.
Magrath IT. Lymphocyte differentiation: an essential basis for the comprehension of lymphoid neoplasia. J Natl Cancer Inst. 1981;67:501–14.
Mann G, Attarbaschi A, Steiner M, et al. Early and reliable diagnosis of non-Hodgkin lymphoma in childhood and adolescence: contribution of cytomorphology an flow cytometric immunophenotyping. Pediatr Hematol Oncol. 2006;23:167–76.
Michot JM, Lazarovici J, Ghez D, et al. Challenges and perspectives in the immunotherapy of Hodgkin lymphoma. Eur J Cancer. 2017;85:67–77.
Murphy SB. Classification, staging and end results of treatment of childhood non Hodgkin’s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332–9.
Neth O, Seidemann K, Jansen P, et al. Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: clinical features, treatment, and results in trials NHL 86 and 90. Med Pediatr Oncol. 2000;35:20–7.
Omer B, Kadan-Lottick NS, Roberts KB, et al. Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults. Br J Haematol. 2012;158(5):615–25.
Patte C, Auperin A, Michon J, et al. The Societe Francaise d’Oncologie Pediatrique LMB 89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood. 2001;97:3370–9.
Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood B-cell neoplasm with tailored intensification of therapy: a report of the Berlin-Frankfurt-Münster group trial NHL-BFM 90. Blood. 1999;94:3294–306.
Reiter A, Schrappe M, Ludwig W-D, et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood. 2000;95:416–21.
Sandlund JT, Downing JR, Crist WM. Non-Hodgkin’s lymphoma in childhood. N Engl J Med. 1996;334:1238–48.
Schmidt E, Burkhardt B. Lymphoblastic lymphoma in childhood and adolescence. Pediatr Hematol Oncol. 2013;30(6):484–508.
Seidemann K, Tiemann M, Schrappe M, et al. Short-pulse B – non – Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster group trial NHL-BFM 90. Blood. 2001;97:3699–706.
Seidemann K, Tiemann M, Lauterbach I, et al. Primary mediastinal large B- cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group. J Clin Oncol. 2003;21:1782–9.
Song Y, Gao Q, Zhang H, et al. Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study. Leukemia. 2019; https://doi.org/10.1038/s41375-019-0545-2.
Van der Kaaij MAE, Van Echten-Arends J, Simons AHM, et al. Fertility preservation after chemotherapy for Hodgkin lymphoma. Hematol Oncol. 2010;28:168–79.
Wieland A, Kerbl R, Berghold A, et al. C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease. Med Pediatr Oncol. 2003;41:21–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer-Verlag GmbH Germany, part of Springer Nature
About this entry
Cite this entry
Urban, C., Lackner, H. (2021). Hodgkin and Non-Hodgkin Lymphoma. In: Puri, P. (eds) Pediatric Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43559-5_152
Download citation
DOI: https://doi.org/10.1007/978-3-662-43559-5_152
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43558-8
Online ISBN: 978-3-662-43559-5
eBook Packages: MedicineReference Module Medicine